Trial Profile
A randomized, assessor-blind, dose-ranging, phase IIIB, multicenter trial comparing the intubating conditions and time course of block of three different intubating doses (0.45 mg/kg, 0.6 mg/kg, and 1.0 mg/kg) of Zemuron in pediatric and adolescent subjects under general anesthesia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Muscle hypertonia
- Focus Therapeutic Use
- Sponsors NV Organon
- 27 Jan 2017 New trial record